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Highlights 
 
1. Thermoresponsive double hydrophilic copolymers are one of the most important 
candidates of biomaterials and have capability of reversible micellization and 
dissociation responding to the change of temperature. 
2. We prepared thermoresponsive double-hydrophilic glycopolymers (TDHG) 
nanofibers for the first time by a free radical copolymerization and electrospinning 
method. 
3. The cytotoxicity of TDHG nanofibers were investigated for their potential as drug 
carriers in controlled drug delivery for targeting of hepatic cells. 
 
Graphical abstract“cluster-glycoside effect” of PNA-FITC and P(OVNG-co-NVCL) 
 
Abstract 
 The thermoresponsive double-hydrophilic glycopolymer (DHG), Poly 
(6-O-vinyl-nonanedioyl-D-galactose-co-N-vinylcaprolactam) (P(OVNG-co-NVCL)) 
was synthesized via a chemo-enzymatic process and a free radical copolymerization 
and the resulting nanofibers were fabricated using an electrospinning process.  The 
desired lower critical solution temperature (LCST) between 32 and 40 oC of the DHG 
polymers was achieved by adjusting the molar fraction of galactose monomer in the 
copolymers during the synthesis. The thermoresponsive DHG polymers were found to 
have good cytocompatibility with Hela cells as determined by the MTT assay, and 
special recognition of the protein peanut agglutinin (PNA). The drug release 
properties of these newly designed thermoresponsive DHG P(OVNG-co-NVCL) 
nanofibers are temperature regulated, can target specific proteins and have the 
potential application in the field of sustained drug release.  
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1. Introduction 
Stimuli-responsive polymer nanocarriers are widely used in controlled-release 
systems [1-2].  These materials may change their affinity for water so that interior 
channels open or close in response to external stimuli such as temperature or pH 
change [3].  Thermoresponsive double hydrophilic copolymers are one of the most 
important types of biomaterials and have the capability of reversible micellization and 
dissociation responding to the change of temperature [4]. These copolymers, 
containing at least one functional unit such as temperature-responsive, light-sensitive 
and pH-sensitive monomers, have recently attracted significant interest for potential 
applications in drug delivery systems [5-6]. Thus, novel double hydrophilic polymers 
have been developed which can undergo a reversible change of morphology in 
response to the environmental stimuli to provide smart therapy with active drugs [7].  
  In order to modify functionality, to produce smart stimuli-responsive copolymers 
with bioactive molecules, much attention has been focused on the fabrication of 
glycopolymers due to their biocompatibility, biodegradability and the hydrophilic 
nature of the carbohydrate moieties [8-9].  The glycopolymers have been used to 
mimic biological systems such as binding lectins through multipoint interactions [10]. 
In our previous research, thermoresponsive double hydrophilic glycopolymers have 
been investigated and these glycopolymers have shown promising capability for 
protein binding [11]. 
  Recent advances in micro and nanotechnology show that polymer microparticles or 
nanoparticles (NPs), micelles, nanogels, liposomes, dendrimers, and composite 
nanofibers can be used for drug delivery applications [12].  Compared with the 
nanoparticulate systems, electrospun nanofibrous scaffolds have high specific surface 
areas, high porosity, and three-dimensional network structures which can, for instance, 
enhance the adhesion, the proliferation and growth of cells [13].  In addition, using 
tissue engineering, the fibers can also be used as carriers in controlled drug release, 
delivering prolonged or better targeted drug delivery [14]. To the best of our 
knowledge, few reports relating to the thermoresponsive double hydrophilic 
glycopolymers nanofibers for drug controlled release are available. 
In this work, thermoresponsive double-hydrophilic glycopolymeric (TDHG) 
nanofibers were prepared using free radical copolymerization and electrospinning 
methodology [15].  Drug-loaded TDHG nanofibers were also prepared in order to 
investigate the influence of temperature, pH and the nature of the polymer on drug 
release [16].  The cytotoxicity of TDHG nanofibers were also investigated for their 
potential as drug carriers in controlled drug delivery for targeting hepatic cells.  
 
2. Materials and methods 
2.1 Materials 
N-vinyl caprolactam (NVCL) and Phosphate Buffered Saline (PBS) (0.01 M, pH 
7.4) were purchased from Sigma-Aldrich (Shanghai) Trading Co., Ltd. Alkaline 
protease from Bacillus subtilis (EC 3.1.1.3, powder, a crude preparation of alkaline 
serine protease, powder, 200 u/mg) was acquired from the Wuxi Xuemei Technology 
Co. Fluorescein isothiocyanate (FITC), bovine serum albumin (BSA), peanut 
agglutinin (PNA) were purchased from Shanghai BioSun Sci & Tech Co., Ltd.  Hela 
cell, fetal calf serum, trypsin (2.5 g/L) and Dulbecco’s modified eagle’s medium 
(DMEM) were acquired from Hang Zhou jinuo bio-pharmaceutical Technology Co., 
Ltd.  Ethyl acetate, azelaic acid, mercuric acetate, copper acetate, petroleum ether, 
2,2’-Azo-bis-iso-butyronitrile (AIBN, 97%), methyl alcohol, tetrahydrofuran, 
pyridine, sodium bicarbonate, sodium carbonate, sodium chloride, and dimethyl 
sulfoxide (DMSO) were purchased from the China National Medicines Corporation 
Ltd. (Beijing, China).  β-Lactose and calcium chloride were of analytical grade and 
were purchased from the Sinopharm Chemical Reagent Co., Ltd.  All solvents used 
in this work were of analytical grade and were dried by storing over activated 4 Å 
molecular sieves for 24 h prior to use.  All other reagents were used as received. 
Water was distilled before use. 
 
2.2 Preparation of P(OVNG-co-NVCL) 
The polymerizable galactose derivatives, 6-O-vinyl-nonanedioyl-D-galactose 
(OVNG), were synthesized, using alkaline protease as a catalyst, according to a 
previously published protocol in anhydrous pyridine at 50 oC, with stirring at 250 rpm 
for 3-4 days [17-18]. A series of P(OVNG-co-NVCL) were subsequently synthesized 
in dimethylformamide (DMF) with 2, 2’-azodiisobutyronitrile (AIBN) as an initiator 
using molar input ratios of OVNG to NVCL of 1:1, 1:4, 1:6, 1:8 (mol/mol).  In a 
typical protocol, OVNG (0.2 g) and NVCL (0.0915 g/0.1489 g) were dissolved in 
DMF (1.0 mL)，AIBN (0.00583 g/0.010978 g, 2% of total mass, w/w) was 
subsequently added after the two monomers dissolved under an atmosphere of N2. 
The polymerization was carried out at room temperature for 8 h.  The resulting 
products were subjected to three dissolutions (in methanol) – coaguline (by diethyl 
ether) cycles and then dried under vacuum. Giving a yield of 78%-80%.  
 
Scheme.1 
 
2.3 Characterization  
1H NMR measurements were performed on an Advance (Bruker, Rheinstetten, 
Germany) Unity Plus 400 MHz nuclear magnetic resonance spectrometer using D2O 
as the solvent.  FT-IR spectra were obtained between 400 and 4500 cm-1 on a Nicolet 
NEXUS-670 (Nicolet Instrument Corporation, WI, USA) at room temperature.  The 
spectra. The number-average molecular weight (Mn), weight-average molecular 
weight (Mw), and polydispersity (Mw/Mn) of the polymers were determined by gel 
permeation chromatography (GPC) at 35 oC using a Waters 1525 chromatograph 
equipped with a Waters 2414 refractive index detector.  Tetrahydrofuran (THF) was 
used as the mobile phase at a flow rate of 1 mL/min. The GPC columns were 
standardized with narrow dispersity polystyrene in molecular weights ranging from 
4.7×106 to 2350. 
Lower critical solution temperature (LCST) measurements 
The LCST is defined as the temperature when the solution is reduced to 50% of the 
transmittance.  After a whole band (200-900 nm) wavelength scanning, the 
transmittance of polymer aqueous solution (1 mg/mL) was determined at λ=226 nm 
using a PerkinElmer lambda 35 UV-visible spectrophotometer equipped with a 
temperature control unit.  The heating rate of the product cuvette and the reference 
cuvette was set as 2 oC·min-1.  
 
2.4 Lectin-binding tests 
P(OVNG-co-NVCL) Glycopolymers have a common structure feature such as 
galactosyl, which can be studied for the binding interaction between lectin and 
carbohydrates.  A typical procedure is described as follows: a stock solution of 
P(OVNG-co-NVCL) in PBS (pH=7.4) at a concentration of 1.5 mg/mL was added to 
a solution of FITC-PNA (1.317 mg/mL) in PBS, to which was added CaCl2(1mM), 
and BSA (1mg)  and these were mixed together and kept at 4 oC for 1 h in the dark, 
then dialysed in PBS (pH=7.4) for 48 h at room temperature.  Images of the 
FITC-PNA binding to the glycopolymers were recorded using a confocal laser 
scanning microscope (Carl Zeiss LSM700, Jena, Germany). 
 
2.5 In vitro cytotoxicity studies 
Hela cells (Rochen biotechnology, Shanghai, China) were seeded into 96-well 
plates at a density of 6,000 cells per well, and grown for 24 h.  The cells were then 
incubated with a series of glycopolymers P(OVNG-co-NVCL) in different 
concentrations for 48 h.  After washing the cells with PBS buffer, fresh DMEM 
medium (100 µL) and 10 µL of MTT solution (5 mg/mL) were added to each well and 
the plates were incubated at 37 oC for another 3 h.  After incubation, the culture 
medium was removed and 50 µL of DMSO was added to each well and shaken for 10 
min at ambient temperature to make the internalized purple formazan crystals 
dissolved.  The absorbance was measured at a wavelength of 570 nm using a plate 
reader (MULTSIKANMK3, Thermo USA).  Each experiment was conducted in 5 
replicates per plate, four plates were used and the results were expressed as a 
percentage of cell viability.  
 
2.6 Preparation of drug-loaded composite nanofibers 
P(OVNG-co-NVCL) nanofibrous mats were first prepared without ferulic acid.  In 
order to achieve better fibrous morphologies and diameters, a L9 (3) 4 orthogonal 
analysis table was used to show conditions, the orthogonal experiment design and 
analysis were figured out by orthogonal design assistant ΙΙ V3.1.1. 
P(OVNG-co-NVCL) homogeneous solutions of 35, 37, and 39 wt% were prepared by 
dissolving P(OVNG-co-NVCL) powder in ethanol at ambient temperature under 
stirring for 12 h.  Electrical voltages were set at 12, 13.5, and 15 kV, with three 
distances (12, 15, and 18 cm) respectively between the syringe tip and the collection.  
The feed rates of solutions were maintained at 0.3, 0.5, and 0.7 mL/h using a single 
syringe pump.  The electrospinning process was carried out at ambient conditions 
(ambient temperature, relative humidity of 60±3%).  The homogeneous spinning 
solutions were loaded in a 1 mL syringe fitted with a stainless steel capillary needle 
with an internal diameter of 0.5 mm and the fibers were collected one a piece of 
aluminum foil. The fibers were visualized using scanning electron microscopy (SEM; 
JSM-5600 LV microscope, JEOL, Tokyo, Japan), and analyzed for average diameters.  
The best spinning conditions (39 wt%, 12 kV, 18 cm, 0.7 mL/h) were selected so as to 
form nanofibers with minimum average diameter.  
 
Table 1 
 
P(OVNG-co-NVCL) and ferulic acid (FA) were dissolved in ethanol at ambient 
temperature under gentle stirring overnight, to achieve a homogeneous solution.  The 
concentration of P(OVNG-co-NVCL) was fixed at 39 wt%, and fibers were 
synthesized with different quantities of FA (5%, 10% and 20 wt% FA) in the blend 
membranes.  Drug-loaded P(OVNG-co-NVCL) solutions were then used for 
electrospinning.  
 
2.7 SEM measurements 
The surface topology of the glycopolymer nanofibers, before and after drug 
insertion was analyzed using scanning electron microscopy (S-4800, Japan Hitachi).  
A sample of about 2 mm2 was attached to the plate, and the samples were 
sputter-coated with gold for 30 seconds to improve its electroconductivity.  The 
diameters of the electrospun fibers were analyzed using Image J software using more 
than 60 images from each sample of fiber. 
 
2.8 TGA analysis 
The thermo gravimetric analyses were performed using a TG 209 F1 (TA 
Instruments Co., DE, USA), in a nitrogen atmosphere and dynamic conditions, over 
the temperature range from 10 oC to 900 oC with a heating rate of 10 oC/min.  The 
data were collected and processed using a Proteus Analysis data system from Netzsch.  
 
2.9 In vitro release study 
In the controlled drug release study ferulic acid (FA) was used as the model drug 
during the electrospinning procedure.  Glycopolymer fibers electrospun from 
solutions A, B and C, each weighing about 25 mg (encapsulating about 5%, 10% of 
FA) were soaked in 5 mL of PBS (pH=7.4) in a dialysis bag with PBS (pH=7.4) in 
glass vials as dialysate.  At various times, 3 mL of the supernatant was removed 
from the vial, and replaced by an equal volume of fresh medium.  Drug release was 
carried out at 20 oC and 40 oC separately.  The concentrations of FA in supernatant 
were then monitored using a UV-visible spectrophotometer at an optical wavelength 
of 254 nm (UV-2102 PC, Shanghai, China). All the processes were carried out for 
three times [19].  
 
3. Results and Discussion  
3.1 Synthesis of P(OVNG-co-NVCL) 
In this study, galactose-functionalized thermoresponsive double hydrophilic 
statistical copolymers were prepared by combining enzymatic synthesis with free 
radical polymerization.  N-vinyl caprolactam (NVCL) and galactose were chosen as 
the thermoresponsive moiety and bioactive component respectively.  
The galactose-functionalized copolymers were prepared by AIBN initiated radical 
copolymerization of 6-O-vinyl-nonanedioyl-D-galactose (OVNG) with NVCL and 
fully characterized by 1H NMR and GPC.  1H NMR data (Fig. 1) of the copolymers 
revealed the absence of vinyl groups and the existence of NVCL and galactose groups. 
From the 1H NMR spectra, the molar ratio of OVNG to NVCL monomers in the 
copolymers could be approximately calculated.  A series of copolymers with 
different molecular weights were obtained by varying the OVNG/NVCL feed molar 
ratios (Table 2).  
Characterization data for P(OVNG-co-NVCL) are as follows: 5.20-4.30 (1H, br. S, 
H-6; d, 5H of D-galactose; 1H, -CHCH2-), 4.04-2.80 (3H of D-galactose), 2.48-2.00 
(2H, m, H-5; 4H, 2-CH2-), 1.90-1.12 (8H, overlap, H-2, H-3, H-4, H-7; 4H, 2-CH2-). 
IR (ATR): ν (cm-1): 1721 (O-C=O), 1607 (N-C=O), 3380(-OH).  
The chemical composition of the P(OVNG-co-NVCL) samples were calculated from 
the ratio of the peak integrals of the protons of HOVNG (δ 2.48-2.00) with protons of 
HNVCL (δ 1.90-1.12).  It was determined that the OVNG contents (w/w) were 52.38% 
(OVNG: NVCL=1:1, mol/mol), 36.36% (OVNG: NVCL=1:4, mol/mol), 28.31% 
(OVNG: NVCL=1:6, mol/mol), and 22.34% (OVNG: NVCL=1:8, mol/mol)  
3.2 Lower critical solution temperature (LCST) measurements 
To confirm the LCST behavior of P(OVNG-co-NVCL) the temperature dependence 
of the solution transmittance was monitored by UV-visible spectrophotometry (Fig. 
2B).  It was found that the LCST values of P(OVNG-co-NVCL) mol/mol) were 30.4, 
32.7, 40.8, and 47.8 oC respectively when the OVNG content is increased from 22.3%, 
28.3%, to 36.3% and 52.3%.  The LCST shifts to a higher temperature with the ratio 
of OVNG due to the increasing hydrophilicity of the glycopolymer [20-21]. The 
LCST values of P(OVNG-co-NVCL) are close to the body temperature, which 
broadens its use [22]. 
3.3 Lectin-binding assay 
As it was mentioned above, the glycopolymers are able to recognize specific 
proteins, because glycopolymers with pedant sugar moieties exhibit an enormous 
advantage compared to single sugar units as the former are capable of multivalent 
binding to lectins (carbohydrate-binding proteins) in a process known as the 
“cluster-glycoside effect”[23].  Peanut agglutinin (PNA) can specifically bind 
galactose residues, so it was used as a model lectin for the preliminary investigations 
of the biological properties of the galactose-functionalized copolymers [24].  The 
glycopolymers were incubated with FITC-PNA then dialyzed to remove unbound 
PNA and analyzed by fluorescence spectroscopy. 
Fluorescence methods have been used extensively to study the specific adhesion 
of lectin with glycopolymers.  The lectin-binding activity of P(OVNG-co-NVCL) 
were investigated with FITC-PNA, which can efficiently adhere to copolymers 
bearing a terminal galactose moiety by carbohydrate-protein affinity.  Fluorescence 
microscopy images of the thermoresponsive glycopolymers are shown in Fig. 3.  
Bright green fluorescence attributed to FITC was detected from all types of 
glycopolymers treated with FITC-PNA, clearly indicating that FITC-PNA binds to the 
glycopolymers with galactose branched chain.  Different fluorescence images were 
observed with P(OVNG-co-NVCL), with those having a longer length of galactose 
branch being easily identified and can label the target lectin by means of the 
clustering effect of carbohydrates and fluorescence from FITC. Fluorescence 
glycopolymer spots can be observed obviously for P(OVNG-co-NVCL), which 
indicates that P(OVNG-co-NVCL) show good lectin-binding activity. 
However, the results from the fluorescence of the clusters varied significantly 
depending on the concentration of the galactose residues.  The quantity of clustering 
for P(OVNG-co-NVCL) increases as the OVNG contents decrease from 52.3% to 
22.3%.  Less OVNG content may affect the binding behavior and lead to 
considerable clustering.  With the decrease in galactose monomer content, other 
recognition sites of lectin could still identify other glycopolymer molecules. Certainly, 
more OVNG could increase the density of the fluorescence. (Fig. 3b and Fig. 3c). 
3.4 Cytotoxicity assays 
  MTT cell viability assays were utilized to evaluate the cytocompatibility of the 
synthesized thermoglycopolymers.  The viability of Hela cells seeded onto the tissue 
culture plates (TCPs) after 1 day of culture in the presence of various formulations of 
P(OVNG-co-NVCL)  are shown in Fig. 4A, with the TCPs being used as a control. 
P(OVNG-co-NVCL, 1:4) showed approximately similar cell viability  to 
P(OVNG-co-NVCL, 1:6). Cell viability varies from 94% to 90% for P 
(OVNG-co-NVCL, 1:1) and littler higher for P(OVNG-co-NVCL, 1:8) from 98% to 
92%. This might be ascribed to the structure status in the medium; more NVCL or 
galactose could provide an appropriate microenvironment for cell attachment and 
migration.  P(OVNG-co-NVCL) is non-toxic even in the highest concentration of 
100 mg/L.  The cell viability cultured on the five materials exceeded 75% (P>0.05, 
no significant difference), thus all five glycopolymers have relatively good 
cytocompatibility, which is essential for their biomedical applications. 
P(OVNG-co-NVCL, 1:4) has a better biological recognition ability compared to 
other glycopolymers and the LCST value of the polymer is also similar to body 
temperature. So this polymer was selected for further investigation using different 
concentrations in a second MTT assay and the data in Fig 4B shows that 
P(OVNG-co-NVCL, 1:4) has low cytotoxity. 
 
3.5 Morphologies of nanofiber mats 
Thermoresponsive glycopolymers have been reported to be promising drug 
delivery vehicle because of their good biocompatibility, non-toxicity and temperature 
controlled release of drugs [25]. According to the work discussed above, 
P(OVNG-co-NVCL, 1:4) showed a LCST value (40.7 oC) close to the temperature of 
the human , a better lectin-binding ability and lower cytotoxicity and consequently the  
P(OVNG-co-NVCL, 1:4) was chosen for sustained drug release studies. The 
electrospun P(OVNG-co-NVCL) and FA/P(OVNG-co-NVCL) nanofibers were 
fabricated and characterized by SEM.  The uniform fibrous structures of P 
(OVNG-co-NVCL) material chosen for optimization studies were dependent on 
various parameters including applied high voltage, electrospinning distance and 
solution concentration [26]. 
Fig. 5A shows SEM micrographs of the nanofiber mats formed using 
P(OVNG-co-NVCL).  In the nine pictures the P(OVNG-co-NVCL) nanofibers 
displayed a smooth and flat morphology and relatively uniform diameter distribution. 
Fig. 5B shows the average diameter distribution values of the nanofibers based on a 
selection of electron micrographs of each material (100 fibers).  The morphologies 
of the nanofibers of FA/P(OVNG-co-NVCL) are different from P(OVNG-co-NVCL) 
(Fig. 5A) since more particles exist in the FA-loaded nanofibers as the FA content is 
increased from 5% to 20%, compared with 0%. [27-28].  
3.6 Thermogravimetric analysis of glycopolymers 
The thermal stability of the FA loaded glycopolymers was assessed by 
thermogravimetry.  The analyses were carried out at temperatures ranging between 0 
and 900 oC.  Fig. 6B presents the TG diagrams of the FA, P(OVNG-co-NVCL) and 
P(OVNG-co-NVCL)/FA.  The degradation of the P(OVNG-co-NVCL)/FA occurs 
following four inflexions of the TG curves.  
 
3.7 In vitro drug release 
In order to investigate in vitro drug release, ferulic acid (4-hydroxy-3-methoxy 
cinnamic acid, FA), a natural antioxidant with potential health benefits against 
cardiovascular problems, inflammatory diseases and certain cancers) was selected and 
loaded onto the nanofibers as drug substrate.  Figure 6C shows FA release profiles 
from electrospun P(OVNG-co-NVCL) nanofibers with different FA proportions at 
different temperatures of 20 oC and 40 oC. Experiments were performed in triplicate 
and error bars indicate the standard deviation.  The release kinetics from the sample 
shows two stages: an initial fast release before the inflections (stage I) followed by a 
slow and constant release (stage II) [29].  In stage I, there were initial rapid release 
from the electrospun mats, then the release ceased and the remainder of the drug was 
released in stage II.  Xu et al. [30] had found that the drug release behavior was 
related to the distribution of drug in the fiber mats.  In the process of electrospinning, 
FA molecules exist both at the outer and inner surface of the nanofiber mats [31].  
During the release processes, FA present on the surface dissolved in PBS solution.  
Thereafter, the FA present within the mat diffused into PBS along with the dissolution 
of P(OVNG-co-NVCL), but the quantity was very small and the process was very 
slow.  The encapsulation efficiencies of FA in P(OVNG-co-NVCL) nanofibers 
electrospun from blend solution of P(OVNG-co-NVCL) were found to be 75.4 ± 
3.5% for 5% FA loaded; 82.3 ± 3.6% for 10% FA loaded; and 85.9 ± 3.4% for 20% 
FA loaded.  
For P(OVNG-co-NVCL) with 10% FA at 20 oC, there was an initial burst release 
96.8% within 8 h (Fig.9). In the following 18.5 h to 72 h, the amount of drug released 
reached 97.7%. In sharp contrast, the drug loaded P(OVNG-co-NVCL) composite 
nanofibers showed a relatively sustained FA release from P(OVNG-co-NVCL) /FA. 
Around 15.1%, 18.3% and 15.9% of FA were released from 5 wt%, 10 wt%, 20 wt% 
P(OVNG-co-NVCL) /FA nanofibers at 40 oC, respectively within the first 8 h. And 
then a plateau was reached after 28 h with a release percentage of > 50% for these 
three mix electrospun P(OVNG-co-NVCL) /FA nanofibers with different FA 
proportions. The release percentages of P(OVNG-co-NVCL) /FA (10 wt %) 
nanofibrous mats at 40 oC at 72 h was much lower than that of the 
P(OVNG-co-NVCL) /FA (10 wt %) nanofibers within the 8 h at 20 oC. The sustained 
release profile of FA from P(OVNG-co-NVCL)/FA nanofibers is due to the fact that 
the soluble structure affect the kinetics of drug release. [32]. 
 
4. Conclusion 
In summary, thermoresponsive double-hydrophilic glycopolymer nanofibers have 
been fabricated.  It was found that the LCST values of P(OVNG-co-NVCL), close to 
human body temperature, may be made simply by adjusting the proportion of OVNG 
and NVCL in the polymerization process.  P(OVNG-co-NVCL) showed low 
cytotoxity in MTT cell viability assays.  Moreover，FA-loaded DHG nanofibers were 
successfully prepared using an electrospinning process. In vitro studies showed that 
drug release was highly dependent upon the temperature, crucially, upon the polymer 
forming filament. Therefore, P(OVNG-co-NVCL) nanofibers may have a potential 
application in the design of temperature controlled drug release formulations.  
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Table 1. The specific situation of L9 (3) 4 orthogonal of electrospinning 
Sample 
ID 
Voltage (kV) 
Collection 
Distance (cm) 
Feed rates 
(mL/h) 
Solution 
concentration (wt 
%) 
1 12 12 0.3 35 
2 12 15 0.7 37 
3 12 18 0.5 39 
4 13.5 15 0.5 35 
5 13.5 18 0.3 37 
6 13.5 12 0.7 39 
7 15 18 0.7 35 
8 15 12 0.5 37 
9 15 15 0.3 39 
 
 
 
 
 
 
Table 2. Characterization data for the polymers (SD, n=3) 
Sample ID 
OVNG/NVCL 
(mol/mol) 
Mn a ×10-4 
(Da) 
Mw/Mn a 
OVNG content b (w/w 
%) 
a 1/1 4.189 1.092 52.38 
b 1/4 3.864 1.537 36.36 
c 1/6 3.767 1.062 28.31 
d 1/8 1.867 1.209 22.34 
a Determined by GPC 
b
 Determined by 1H NMR measurements in D2O 
 
 
 
 
Fig. 1(A) The synthesis of P(OVNG-co-NVCL) by controllable regioselective 
enzymatic transesterification and free radical polymerization; (B)1H NMR spectra of 
(a) P(OVNG-co-NVCL) and (b) monomer OVNG 
 
Fig. 2 (A) Infrared spectra of P(OVNG-co-NVCL) at various ratios [a. 
P(OVNG-co-NVCL, 1:8), b. P(OVNG-co-NVCL, 1:6), c P(OVNG-co-NVCL, 1:4), d. 
P(OVNG-co-NVCL, 1:1) and e. OVNG] (B) Temperature dependence of the 
transmittance of aqueous solutions of P(OVNG-co-NVCL) products 
 
Fig. 3 Images of PNA-FITC binding with thermoresponsive P(OVNG-co-NVCL). 
Molar input ratios of OVNG to NVCL: (a) 1: 1; (b) 1: 4; (c) 1: 6; (d) 1: 8 
 
Fig. 4 (A) Proliferation of Hela cells seeded onto tissue culture plates (TCP)  in the 
presence of  P(OVNG-co-NVCL); (B) on P(OVNG-co-NVCL, 1:4) after 1 day’s 
culture label the figure with A and B (SD, n=3) 
 
Fig. 5 (A) SEM images of the fiber mats containing various amounts of FA. The 
concentration of P(OVNG-co-NVCL) was fixed at 35wt% (1-3), 37wt% (4-6), 39wt% 
(7-9), all scale labels are 30 µm. (B) The average diameter distribution values of 
nanofibers 
 
Fig. 6 (A) Representative morphologies of different loaded FA/P(OVNG-co-NVCL) 
nanofibers. (FA content increased from 5% to 20%, compared with 0%); (B) TG 
diagram of the FA, P(OVNG-co-NVCL) and P(OVNG-co-NVCL)/FA; (C) Sustained 
release of FA from P(OVNG-co-NVCL)/FA nanofibers at 20 oC and 40 oC (SD, n=3) 
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